Pyritinol
Clinical data | |
---|---|
ATC code | |
Pharmacokinetic data | |
Elimination half-life | 2.5 hours |
Identifiers | |
| |
JSmol) | |
| |
| |
(what is this?) (verify) |
Pyritinol also called pyridoxine disulfide or pyrithioxine (European drug names Encephabol, Encefabol, Cerbon 6) is a semi-synthetic water-soluble analog of vitamin B6 (Pyridoxine HCl). It was produced in 1961 by Merck Laboratories by bonding 2 vitamin B6 compounds (pyridoxine) together with a disulfide bridge. Since the 1970s, it has been a prescription and OTC drug in several countries for cognitive disorders, rheumatoid arthritis,[1] and learning disorders in children. Since the early 1990s it has been sold as a nootropic dietary supplement in the United States.
Availability
It is approved for "symptomatic treatment of chronically impaired brain function in dementia syndromes" and for "supportive treatment of sequelae of craniocerebral trauma" in various European countries, including Austria, Germany, France, Italy, Portugal, and Greece. In France it is also approved for
Effects
review refs needed
Adverse effects
Adverse effects include nausea, headache,
Other rare side effects: acute pancreatitis[5] and photoallergic eruption.[6]
See also
References
External links
- Media related to Pyritinol at Wikimedia Commons